http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
BioLife Solutions' CryoStor® Integrated in Kolon Group's Cell-Mediated Gene Therapy for Osteoarthritis
-
BioLife Solutions Reports Results for Second Quarter 2016
-
BioLife Solutions (BLFS), Bellicum Pharmaceuticals (BLCM) Enter CryoStor Supply Agreement
-
BioLife Solutions Executes 10 Year Supply Agreement with Bellicum Pharmaceuticals for CryoStor® Use in Cellular Immunotherapies
-
BioLife Solutions to Report Second Quarter 2016 Financial Results and Provide Business Update on August 11, 2016
-
BioLife Solutions (BLFS) Announces Products Embedded in Cook MyoSite Phase 3 Cell Therapy Clinical Trial
-
BioLife Solutions Products Embedded in Cook MyoSite® Phase 3 Cell Therapy Clinical Trial for Stress Urinary Incontinence
-
Pre-Open Stock Movers 07/11: (BLFS) (SGNT) (IMPV) Higher; (CJES) (TWTR) (CHTR) Lower (more...)
-
BioLife Solutions (BLFS), Kite Pharma (KITE) Enter Long-Term CryoStor Supply Agreement
-
BioLife Solutions Executes 10 Year Supply Agreement with Kite Pharma for CryoStor® Use in CAR T Cell Therapies
-
BioLife Solutions and MNX Global Logistics Partner to Support ImmunoCellular Therapeutics with Cold Chain Logistics in ICT-107 Phase 3 Clinical Trial in Glioblastoma
-
BioLife Solutions Appoints Jim Mathers as New Vice President of Sales
-
BioLife Solutions Reports First Quarter 2016 Results
-
BioLife Solutions to Report First Quarter 2016 Financial Results and Provide Business Update on May 12, 2016
-
BioLife Solutions (BLFS) Names New CFO, Secretary
-
BioLife Solutions Names Roderick de Greef Chief Financial Officer & Secretary
-
Seattle Business Magazine Names BioLife Solutions Washington State Manufacturer of the Year
-
Biologistex LLC and MNX Global Logistics Partner to Offer Enhanced Cold Chain Logistics Services for Time and Temperature Sensitive Biologics, Vaccines & Cell Therapies
-
BioLife Solutions Names Cord Blood Industry Veteran Karen Foster Vice President of Operations
-
BioLife Solutions Provides Update on Customer Cell Therapy Clinical Trials and Development Programs
-
BioLife Solutions to Present at 28th Annual ROTH Conference and 4th Annual ARM Cell & Gene Therapy Investor Day
-
BioLife Solutions (BLFS) Appoints New CFO
-
BioLife Solutions Names Roderick de Greef Interim Chief Financial Officer
-
BioLife Solutions Reports 4th Quarter and Full Year 2015 Results
-
BioLife Solutions to Report Fourth Quarter 2015 Financial Results and Provide Business Update on February 25, 2016
-
BioLife Solutions Distributor STEMCELL Technologies Will Test the evo™ Smart Shipper and Cloud Based biologistex™ Cold Chain Management App
-
BioLife Solutions Makes Deloitte 2015 Technology Fast 500™
-
BioLife Solutions Reports 3rd Quarter 2015 Results
-
BioLife Solutions to Report Third Quarter 2015 Financial Results and Provide Business Update on November 12, 2015
-
BioLife Solutions to Present at Upcoming Investor Conferences
-
BioLife Solutions Announces HemaCare Will Validate the evo™ Smart Shipper and Cloud Based biologistex™ Cold Chain Management App
-
BioLife Solutions CryoStor® Commercial Grade Freeze Media Embedded in TC Biopharm ImmuniCell® Clinical Trial for Various Cancers
-
Market Wrap: Crude Staves-Off Loss for August; Apple, Cisco Enter Partnership; Twitter Gains on Upgrade
-
Pre-Open Stock Movers 08/31: (VTL) (MDCO) (TWTR) Higher; (ARIA) (AUY) (UTX) Lower (more...)
-
BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint
-
BioLife Solutions Reports 2nd Quarter 2015 Results
-
BioLife Solutions to Report Second Quarter 2015 Financial Results and Provide Business Update on August 6, 2015
-
BioLife Solutions Readies New BloodStor® 27 NaCl Cryopreservation Media to Support Customer Clinical Use of Frozen Platelets
-
BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State
-
BioLife Solutions CryoStor® Cited in New Journal Article on Results of Phase I/II Clinical Trial of Dendritic Cell Immunotherapy for Prostate Cancer
-
BioLife Solutions Reports Increased Adoption of CryoStor® and HypoThermosol® Clinical Grade Biopreservation Media Products and Strong Interest in Cloud Based biologistex™ App & evo™ Smart Sh
-
BioLife Solutions to Sponsor, Present, and Exhibit at the 2015 ISCT Conference: May 27 - 30 in Las Vegas
-
BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City
-
BioLife Solutions Reports 1st Quarter 2015 Results
-
BioLife Solutions to Report First Quarter 2015 Financial Results and Provide Business Update on May 7, 2015
-
BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products
-
Cord Blood Registry® Uses BioLife Solutions CryoStor® Clinical Grade Freeze Media in the Storage of Umbilical Cord Tissue Stem Cells
-
BioLife Solutions Announces Preliminary Q1 2015 Revenue of $1.5 Million and Continued Product Adoption in the High Growth Regenerative Medicine Market
-
BioLife Solutions CryoStor® Cell Preservation Media Embedded in Cardio3 BioSciences' Phase III Clinical Trials of C-Cure® Cell Therapy for Congestive Heart Failure
-
BioLife Solutions Announces Fourth Quarter and Full Year 2014 Financial Results

